Quarterly Results

ELDER PHARMACEUTICALS LTD.

NSE : NABSE : 532322ISIN CODE : INE975A01015Industry : Pharmaceuticals & DrugsHouse : Elder
BSE38.000 (0 %)
PREV CLOSE ( ) 38.00
OPEN PRICE ( ) 38.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20547
TODAY'S LOW / HIGH ( )37.10 38.00
52 WK LOW / HIGH ( ) 37.138
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2015
Dec 2014
Sep 2014
Jun 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1520.63
1579.26
2031.38
1202.25
Total Expenditure
1636.55
1884.51
2287.14
2683.9
PBIDT (Excl OI)
-115.92
-305.25
-255.76
-1481.65
Other Income
10.52
9.38
93.22
21.23
Operating Profit
-105.4
-295.87
-162.54
-1460.42
Interest
224.56
450.49
231.82
1200.08
Exceptional Items
2.74
NA
40.33
3688.54
PBDT
-327.22
-746.36
-354.03
1028.04
Depreciation
104.2
89.28
113.21
63.01
Profit Before Tax
-431.42
-835.64
-467.24
965.03
Tax
28.8
NA
1.49
-0.49
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-460.22
-835.64
-468.73
965.52
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-460.22
-835.64
-468.73
965.52
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-460.22
-835.64
-468.73
965.52
Equity Capital
205.37
205.37
205.37
205.37
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-22.40
-40.68
-22.82
47.01
Calculated EPS (Annualised)
-89.63
-162.75
-91.29
188.05
No of Public Share Holdings
15354553
14811553
14811553
15349156
% of Public Share Holdings
74.77
72.12
72.12
74.74
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-7.62
-19.32
-12.59
-123.23
PBIDTM%
-6.93
-18.73
-8.00
-121.47
PBDTM%
-21.51
-47.26
-17.42
85.50
PBTM%
-28.37
-52.91
-23.00
80.26
PATM%
-30.26
-52.91
-23.07
80.30
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.